Filing Details
- Accession Number:
- 0001651844-19-000017
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-28 15:53:22
- Reporting Period:
- 2019-06-27
- Accepted Time:
- 2019-06-28 15:53:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1018735 | Nymox Pharmaceutical Corp | NYMX | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1651844 | George James Robinson | 10 East Lee Street Suite 2705 Baltimore MD 21202 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-06-27 | 1,733 | $1.56 | 3,453,283 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-27 | 32 | $1.56 | 3,453,315 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-27 | 6,235 | $1.56 | 3,459,550 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-27 | 473 | $1.55 | 3,460,023 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-27 | 527 | $1.54 | 3,460,550 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |